Drug intelligence / Profile preview

liposomal SPARC peptide

Development stage
Preclinical
Lead developer
Wake Forest University School of Medicine
Modality
Peptides, Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

Liposomal SPARC peptide is an experimental therapeutic formulation consisting of a peptide derived from the SPARC (Secreted Protein Acidic and Rich in Cysteine) protein encapsulated within a liposomal delivery system. The drug is designed to mimic a naturally occurring age-associated protective mechanism in the brain. Research indicates that aging activates MT1G/NFκB signaling in reactive astrocytes, leading to the secretion of SPARC, which inhibits brain metastasis. The liposomal SPARC peptide acts by targeting and inhibiting Integrin Beta 1 (ITGB1) signaling in tumor cells, thereby suppressing tumor growth and limiting the colonization of the brain by lung cancer cells. This targeted therapy is specifically being investigated to prevent or treat brain metastasis in younger lung cancer patients who lack the elevated SPARC levels typically found in older populations.

Other names
liposome-encapsulated SPARC peptide
02

Targets

ITGB1 (Integrin beta-1)

Beyond the preview

Go deeper on liposomal SPARC peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on liposomal SPARC peptide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call